Company: AEMD
Filing Date: 2025-06-26
Form Type: 10-K
Source: 0001683168-25-004780
Chunk: 1128

Company: AETHLON MEDICAL INC
Filing Date: 2025-06-26
Form: 10-K
Item: Item 7A
Chunk 1128
---
 into, modified or terminated a
“Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” that were intended to satisfy the
affirmative defense conditions of Rule 10b5-1, in each case as defined in Item 408 of Regulation S-K.

ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT
INSPECTIONS

Not applicable.

 61 

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

The names, ages and positions
of our directors and executive officers as of June 26, 2025 are listed below:

    NAMES
     
    TITLE OR POSITION(1)
     
    AGE
  
    James B. Frakes
     
    Chief Executive Officer, Chief Financial Officer and Director
     
    68

    Edward G. Broenniman
     
    Chairman and Director
     
    88

    Angela Rossetti
     
    Director
     
    71

    Chetan S. Shah, M.D.
     
    Director
     
    55

    Nicolas Gikakis
     
    Director
     
    58

    Steven P. LaRosa, M.D.
     
    Chief Medical Officer
     
    58

    (1)
    Our Board of Directors has determined that Mr. Broenniman, Mr. Gikakis, Ms. Rossetti and Dr. Shah meet the requirements to be determined as “independent directors” for all purposes, including Compensation Committee and Audit Committee purposes, under the Nasdaq Stock Market (“Nasdaq”) rules and for federal securities law purposes. Mr. Frakes is not independent, as he also functions as executive and officer of the Company.

Certain additional information
concerning the individuals named above is set forth below. This information is based on information furnished to us by each individual
noted.

James B. Frakes Chief Executive Officer,
Chief Financial Officer and Director

Mr. Frakes has served as Chief
Executive Officer and Chief Financial Officer since October 3, 2024, having previously served as Interim Chief Executive Officer beginning
in November 2023. He has also served as a director of the Company since November 2023, and has held the role of Chief Financial Officer
of the Company since September 2010. Prior